Exposure to Chemical in Roundup Increases Long Term Brain Damage, Study Finds
Even short-term Roundup exposure led to brain inflammation, anxiety and early death in mice test subjects, researchers warn.
Tag Archives: Non-Hodgkins Lymphoma
-
-
Reformulated Roundup May Be Even More Toxic to Human Health and Environment: Study
Bayer replaced glyphosate in Roundup amid concerns about the cancer risks. However, chemicals now used in reformulated Roundup may be 45 times more toxic.
-
Philadelphia Jury Awards $78M in Roundup Non-Hodgkin’s Lymphoma Lawsuit
Monsanto and Bayer have lost four out of six Roundup lawsuit trials held in Pennsylvania state court, each involving non-Hodgkin’s lymphoma allegedly caused by the controversial weed killer.
-
Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto
Verdict comes as Bayer and its Monsanto subsidiary prepare to ask the U.S. Supreme Court to intervene in the nationwide Roundup litigation.
-
U.S. Appeals Court Finds Roundup Failure to Warn Claims Preempted by Federal Law
Ruling contradicts an opinion issued by the Eleventh Circuit earlier this year, setting the stage for U.S. Supreme Court to potentially decide whether Roundup lawsuits can move forward over non-Hodgkin's lymphoma risks
-
Study Finds Some Pesticides Carry Cancer Risks Similar to Smoking
Researchers found that non-Hodgkin’s lymphoma cancer risks were 154% higher among those exposed to pesticides than for those who smoke.
-
Study Finds Active Ingredient From Roundup Weed Killers in Human Sperm
Researchers warn that glyphosate in Roundup could deteriorate the blood testes barrier, potentially contributing to infertility or causing DNA damage that could be passed to children.
-
Judge Orders Roundup Lymphoma Lawsuit Payout of $400M, After Reducing Jury Verdict from $2.25B
Payout comes in a Roundup lawsuit filed by a landscaper diagnosed with non-Hodgkin's lymphoma, finding that Bayer and it's Monsanto unit failed to adequately warn about the risks associated with the weed killer.
-
Roundup Lawsuit Costs Continue To Pile Up, With $16 Billion Set Aside to Resolve Non-Hodgkin Lymphoma Claims
Bayer's stock value has plummeted 70% since it purchased Monsanto, and CEO now indicates Roundup lawsuits pose serious threat to future of company
-
Three Roundup Lawsuits Cleared For Remand to Massachusetts Federal Court if Settlement Not Reached
Plaintiffs' expert witness testimony in three lawsuits was found to be "scientifically reasonable," clearing the way for the cases to be returned to the District of Massachusetts for trial.
